Efficacy analysis of laparoscopic sleeve gastrectomy in treating patients with obese polycystic ovary syndrome
- VernacularTitle:腹腔镜下袖状胃切除术对肥胖型多囊卵巢综合征的疗效分析
- Author:
Yangxi HU
1
;
Yan LIU
;
Mengzhu LI
;
Xing DONG
;
Ran LI
;
Wenjuan WANG
;
Jianping YE
;
Hansong LIU
Author Information
- Keywords: sleeve gastrectomy; obesity; polycystic ovary syndrome; hyperandrogenism
- From: Journal of Clinical Medicine in Practice 2024;28(7):49-52
- CountryChina
- Language:Chinese
- Abstract: Objective To observe the therapeutic effect of laparoscopic sleeve gastrectomy(LSG)in treating patients with obesity and polycystic ovary syndrome(PC OS).Methods In this ret-rospective analysis,clinical materials of 60 patients with obesity and PCOS by LSG were analyzed,and postoperative improvements of PCOS symptoms were observed.Results A total of 60 patients had a pre-operative mean body mass index(BMI)of(39.4±5.4)kg/m2 and an average age of(26.3±6.1)years old,and all of them successfully completed LSG.After follow-up of 12 to 18 months,50 cases(83.3％)had normalized menstrual cycles,with an average recovery time of(4.5±2.2)months af-ter surgery,and 7 cases had natural pregnancy after surgery.Before surgery,ultrasound results in 35 patients indicated polycystic ovarian morphology(PCOM),and 29 cases(82.9％)regained normal o-varian status with an average recovery duration of(6.3±2.8)months.Complicated hyperandrogene-mia was observed in 31 patients,and 29 cases(93.5％)exhibited normalization of testosterone levels within 18 months after surgery.At 18 months after surgery,the BMI was(26.47±4.70)kg/m2,the average weight loss was(32.4±7.4)％.Conclusion LSG is a safe and effective treatment for obese PCOS.
